An ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended to instill, administer, or deliver drug/medicine to the eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue. Ocular drug formulations are primarily liquid forms, such as solutions, suspensions, and emulsions for treating anterior eye segment diseases. These formulations can be available in the form of advanced drug delivery systems like in-situ gel, microemulsion, nanoparticle, liposome, iontophoresis, nanosuspension, and ocular inserts.
The leading cause of blindness or low vision across the globe is cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and unaddressed refractive error. The majority of the global population have or had some eye disorder in their lifetime. As per the World Health Organization (WHO) report “Blindness and vision impairment” published in February 2021, around 2.2 billion people worldwide have a near or distance vision impairment. It has also estimated that the leading cause of vision loss or low vision is cataract (94 million) and uncorrected refractive errors (88.4 million). Further, the other common causes of vision loss are glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million).
According to the National Eye Institute (NEI), in the US, the number of people with cataracts is expected to double from 24.4 million in 2010 to about 50 million in 2050. Similarly, as per the Factsheet Glaucoma: Facts & Figures 2019, over 3 million people in the US were living with glaucoma. Moreover, as per the Canadian Survey on Disabilities 2017, 1.5 million Canadians had a sight loss, and around 5.59 million had an eye disease which could further lead to sight loss.
Additionally, as per the Royal National Institute of Blind People in 2017, in the UK, there were around 350,000 people registered as blind and partially sighted; about 173,735 were registered for severely sight impaired; and 176,125 were registered for sight-impaired.
The COVID-19 pandemic has become the most significant challenge across the world. As this pandemic has stressed healthcare systems across the globe, prioritizing the limited resources was essential to minimize hospital admissions. However, despite increased demand for ocular therapeutics such as eye drops, ointment, and suspension, there was a shortage of these products as new consumers entered the market. Manufacturers are also experiencing raised prices and potential shortages of raw ingredients due to supply restrictions. However, as the restrictions have been lifted and businesses are resuming, the demand-supply variables are coming back to normal. This will offer several growth prospects for ocular drug delivery therapeutics.
Based on technology, the ocular drug delivery market is segmented into implantable ocular drug delivery systems, particulate drug delivery systems, nano-particle drug delivery systems, and others. The implantable ocular drug delivery systems segment would account for the largest market share in 2021, and the same segment is anticipated to register the highest CAGR during the forecast period.
Based on formulation type, the ocular drug delivery market is segmented into liposomes and nanoparticles, solution, emulsion, suspension, and ointment. The solution segment would hold the largest share of the market in 2021, and it is estimated to register the highest CAGR in the market during 2021-2028. The growth of the solution segment is attributed to the increasing adoption of ocular drug delivery systems in solution forms, like eye drops and injectables.
Based on disease type, the ocular drug delivery market is segmented into glaucoma, diabetic retinopathy, dry eye syndrome, macular degeneration, cataract, diabetic macular edema, and others. The cataract segment would account for the largest market share in 2021. The market for this segment is estimated to grow at the highest CAGR from 2021 to 2028.
Based on end user, the ocular drug delivery market is segmented into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment would hold the largest share of the market in 2021, while the ophthalmic clinics segment is estimated to register the highest CAGR in the market during the forecast period.
National Eye Institute, Royal National Institute of Blind People, American Academy of Ophthalmology, National Health Service, the Food and Drug Administration, the World Health Organization, and the Centers for Disease Control and Prevention of various countries are among the major primary and secondary sources referred to while preparing this report.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Ocular drug delivery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global Ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Ocular Drug Delivery Market - By Technology
1.3.2 Global Ocular Drug Delivery Market - By Formulation Type
1.3.3 Global Ocular Drug Delivery Market - By Disease Type
1.3.4 Global Ocular Drug Delivery Market - By End User
1.3.5 Global Ocular Drug Delivery Market - By Geography
2. Global Ocular Drug Delivery Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Ocular Drug Delivery Market - Market Landscape
4.1 Overview
4.1.1 North America - PEST Analysis
4.1.2 Europe - PEST Analysis
4.1.3 Asia Pacific - PEST Analysis
4.1.4 Middle East And Africa - PEST Analysis
4.1.5 South and Central America - PEST Analysis
4.2 Expert Opinions
5. Ocular Drug Delivery Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Eye Disorders
5.1.2 Rising Research on Ocular Drug Delivery
5.2 Market Restraints
5.2.1 Disadvantages Associated with Ocular Drug Delivery
5.3 Market Opportunities
5.3.1 Increasing Awareness About Vision Care
5.4 Future Trends
5.4.1 Development of Innovative Products
5.5 Impact analysis
6. Ocular Drug Delivery Market - Global Analysis
6.1 Global Ocular Drug Delivery Market Revenue Forecast and Analysis
6.2 Global Ocular Drug Delivery Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Ocular Drug Delivery Market Analysis - By Formulation Type
7.1 Overview
7.1.1 Global Ocular Drug Delivery Market, By Solution 2021 & 2028 (%)
7.2 Liposomes and Nanoparticles Market
7.2.1 Overview
7.2.2 Global Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
7.3 Solution
7.3.1 Overview
7.3.2 Global Solution Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Emulsion
7.4.1 Overview
7.4.2 Global Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Suspension
7.5.1 Overview
7.5.2 Global Suspension Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Ointment
7.6.1 Overview
7.6.2 Global Ointment Market Revenue and Forecasts to 2028 (US$ Million)
8. Ocular Drug Delivery Market Analysis - By End User
8.1 Overview
8.2 Ocular Drug Delivery Market Share, by Technique, 2021 and 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Ophthalmic Clinics
8.4.1 Overview
8.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Ambulatory Surgical Centers
8.5.1 Overview
8.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Asia Pacific: Ocular Drug Delivery Market
8.6.1 Overview
8.6.2 Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.3 Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
8.6.4 Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
8.6.5 Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
8.6.6 Asia Pacific: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
8.6.7 Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
8.6.8 China: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.8.1 China: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.8.2 China: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
8.6.8.3 China: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
8.6.8.4 China: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
8.6.8.5 China: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
8.6.9 Japan: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.9.1 Japan: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.9.2 Japan: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
8.6.9.3 Japan: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
8.6.9.4 Japan: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
8.6.9.5 Japan: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
8.6.10 India: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.10.1 India: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.10.2 India: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
8.6.10.3 India: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
8.6.10.4 India: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
8.6.10.5 India: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
8.6.11 Australia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.11.1 Australia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.11.2 Australia: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
8.6.11.3 Australia: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
8.6.11.4 Australia: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
8.6.11.5 Australia: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
8.6.12 South Korea: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.12.1 South Korea: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.12.2 South Korea: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
8.6.12.3 South Korea: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
8.6.12.4 South Korea: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
8.6.12.5 South Korea: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
8.6.13 Rest of Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.13.1 Rest of Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
8.6.13.2 Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
8.6.13.3 Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
8.6.13.4 Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
8.6.13.5 Rest of Asia Pacific: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
8.7 Middle East and Africa: Ocular Drug Delivery Market
8.7.1 Overview
8.7.2 Middle East & Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.3 Middle East and Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
8.7.4 Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
8.7.5 Middle East and Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
8.7.6 Middle East and Africa: Ocular Drug Delivery Market, by End Users - Revenue and Forecast to 2028 (US$ Million)
8.7.7 Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
8.7.7.1 Saudi Arabia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.1.1 Saudi Arabia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.1.2 Saudi Arabia: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
8.7.7.1.3 Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.1.4 Saudi Arabia: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.1.5 Saudi Arabia: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
8.7.7.2 UAE: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.2.1 UAE: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.2.2 UAE: Ocular Drug Delivery Market , by Technology - Revenue and Forecast to 2028 (US$ Million)
8.7.7.2.3 UAE: Ocular Drug Delivery Market , by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.2.4 UAE: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.2.5 UAE: Ocular Drug Delivery Market , by End User - Revenue and Forecast to 2028 (US$ Million)
8.7.7.3 South Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.3.1 South Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.3.2 South Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
8.7.7.3.3 South Africa: Ocular Drug Delivery Market , by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.3.4 South Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.3.5 South Africa: Ocular Drug Delivery Market, by End user - Revenue and Forecast to 2028 (US$ Million)
8.7.7.4 Rest of Middle East and Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.4.1 Rest of Middle East and Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
8.7.7.4.2 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
8.7.7.4.3 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.4.4 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
8.7.7.4.5 Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User - Revenue and Forecast to 2028 (US$ Million)
8.8 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
8.9 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies Done by the Companies in the Market, (%)
9.3 Organic Developments
9.3.1 Overview
9.4 Inorganic Developments
9.4.1 Overview
10. Company Profiles
10.1 AbbVie Inc.
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bausch Health Companies Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Taiwan Liposome Company, Ltd.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Ocular Therapeutix, Inc.
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 GRAYBUG VISION, INC.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Alimera Sciences, Inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Envisia Therapeutics
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Novartis AG
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 EYEGATE PHARMACEUTICALS, INC
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Clearside Biomedical, Inc.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
List of Tables
Table 1. Asia Pacific: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 2. Technology
Table 3. Asia Pacific Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
Table 4. Formulation Type
Table 5. Asia Pacific Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 6. Disease Type
Table 7. Asia Pacific Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 8. End User
Table 9. China: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 10. Technology
Table 11. China: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
Table 12. Formulation Type
Table 13. China: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 14. Disease Type
Table 15. China: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 16. End User
Table 17. Japan: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 18. Technology
Table 19. Japan: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
Table 20. Formulation Type
Table 21. Japan: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 22. Disease Type
Table 23. Japan: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 24. End User
Table 25. India: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 26. Technology
Table 27. India: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
Table 28. Formulation Type
Table 29. India: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 30. Disease Type
Table 31. India: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 32. End User
Table 33. Australia: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 34. Technology
Table 35. Australia: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
Table 36. Formulation Type
Table 37. Australia: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 38. Disease Type
Table 39. Australia: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 40. End User
Table 41. South Korea: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 42. Technology
Table 43. South Korea: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
Table 44. Formulation Type
Table 45. South Korea: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 46. Disease Type
Table 47. South Korea: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 48. End User
Table 49. Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 50. Technology
Table 51. Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
Table 52. Formulation Type
Table 53. Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
Table 54. Disease Type
Table 55. Rest of Asia Pacific: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 56. End User
List of Figures
Figure 1. Ocular Drug Delivery Market Segmentation
Figure 2. Ocular Drug Delivery Market Segmentation, By Region
Figure 3. Global Ocular Drug Delivery Market Overview
Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Ocular Drug Delivery Market, by Geography (US$ Million)
Figure 7. Global Ocular Drug Delivery Market - Leading Country Markets (US$ Million)
Figure 8. Global Ocular Drug Delivery Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Ocular Drug Delivery Market Impact Analysis of Driver and Restraints
Figure 15. Global Ocular Drug Delivery Market - Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Ocular Drug Delivery Market - By Geography Forecast and Analysis - 2021- 2028
Figure 17. Market Positioning of Key Players in Global Ocular Drug Delivery Market
Figure 1. Global Ocular Drug Delivery Market, By Solution 2021 & 2028 (%)
Figure 2. Global Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 3. Global Solution Market Revenue and Forecasts to 2028 (US$ Million)
Figure 4. Global Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
Figure 5. Global Suspension Market Revenue and Forecasts to 2028 (US$ Million)
Figure 6. Global Ointment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 7. Medical devices market Share, by Technique, 2021 and 2028 (%)
Figure 8. Hospitals: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Million)
Figure 9. Ophthalmic Clinics: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Thousand)
Figure 10. Ambulatory Surgical Centers: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Thousand)
Figure 11. Asia Pacific: Ocular Drug Delivery Market, by Key Country - Revenue (2021) (USD Million)
Figure 12. Asia Pacific Ocular Drug Delivery Market Revenue and Forecast to 2028 (USD Million)
Figure 13. Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
Figure 14. China: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
Figure 15. Japan: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
Figure 16. India: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
Figure 17. Australia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
Figure 18. South Korea: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
Figure 19. Rest of Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
Figure 20. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Bausch Health Companies Inc.
- Taiwan Liposome Company, Ltd.
- Ocular Therapeutix, Inc.
- GRAYBUG VISION, INC.
- Alimera Sciences, Inc.
- Envisia Therapeutics
- Novartis AG
- EYEGATE PHARMACEUTICALS, INC
- Clearside Biomedical, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 171 |
| Published | September 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 16404.32 Million |
| Forecasted Market Value ( USD | $ 27016.2 Million |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
